NXNL1 Polyclonal Antibody
Sizes: 60μL, 120μL, 200μL
Catalogue Numbers: E-AB-52711-60, E-AB-52711-120, E-AB-52711-200
Citations, Manuals and MSDS Available upon request.
Abbreviation: NXNL1
Target Synonym: Nucleoredoxin like 1; Nucleoredoxin-like protein 1; Nxnl1; NXNL1; RDCVF; Rod derived cone viability factor; Thioredoxin like 6; Thioredoxin-like protein 6
Research Areas: Cell Biology, Metabolism
Conjugation: Unconjugated
Host: Rabbit
Species Reactivity: Human
Application: IHC, ELISA
Isotype: IgG
Clonality: Polyclonal
UNIProt ID: Q96CM4
Background: Retinitis pigmentosa (RP) is a disease that leads to blindness by degeneration of cone photoreceptors. Rods produce factors required for cone viability. The protein encoded by this gene is one of those factors and is similar to a truncated form of thioredoxin. This gene has been proposed to have therapeutic value against RP.
Concentration: 0.78 mg/mL
Immunogen: Fusion protein of human NXNL1
Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4
Purification Method: Antigen affinity purification
Dilution: IHC 1:30-1:150, ELISA 1:5000-1:10000
Storage: -20°C/One year. Avoid freeze / thaw cycles.
Shipping: Ice bag
Research Use Only